Plus: Benefits of reducing antipsychotic medication dose during maintenance treatment of stable patients. Read more inside.
View web version
 

April 5, 2018

Welcome to the Schizophrenia Advisor Channel e-newsletter from PsychiatryAdvisor.com

 
 
Schizophrenia Advisor Channel
 
 
Potential for SERMs as Adjunctive Therapy for Schizophrenia
 
 
Reduced Schizophrenia Maintenance Dose Improves Cognitive Function, Negative Symptoms
 
Treatment-Resistant Schizophrenia or Medication Underexposure?
 
Intranasal Oxytocin Reduces Negative Effects, Improves Cognitive Function in Schizophrenia
 
Self-Stigmatization Affects Medication Adherence in Schizophrenia
 
Psychotic Disorders Associated With Early Dynamic Cognitive Impairment
Clinical Advisor
Schizophrenia: Diagnosis and Management
 
 

Want to receive emails specific to your profession and specialty? Click here to complete your profile.